Betting on dopamine

CNS Spectrums

Volumn 10, Issue 4, 2005, Pages 268-270

  Stein, Dan J ^a,b   Grant, Jon E ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF FLORIDA   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; DOPAMINE; LEVODOPA; PERGOLIDE; RISPERIDONE; SELEGILINE;

ADULT; ARTICLE; CASE REPORT; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; LOW DRUG DOSE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SPEECH; SYMPTOM; TREATMENT OUTCOME;

EID: 17144383182     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900022574     Document Type: Article

References (20)

1. Seedat S, Kesler S, Niehaus DJ, Stein DJ. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety. 2000;11:185-186.
2. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. Adv Neurol. 1995;65:115-138.
3. Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002;58:11-17.
4. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 299, 1898-1902. 2003.
5. Knutson B, Fong GW, Adams CM, Varner JL, Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport. 2001;12:3683-3687.
6. Martinez D, Slifstein M, Broft A, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the stratum. J Cereb Blood Flow Metab. 2003;23:285-300.
7. Potenza MN, Steinberg MA, Skudlarski P, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2003;60:828-836.
8. Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science. 2004;306:1940-1943.
9. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologa. 2003;41:1431-1441.
10. Black DW, Moyer T, Schlosser S. Quality of life and family history in pathological gambling. J Nerv Ment Dis. 2003;191:124-126.
11. Ramirez LF, McCormick RA, Russo AM, Taber JI. Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav. 1983;8:425-428.
12. Ibanez A, Blanco C, de Castro IP, Fernandez-Piqueras J, Saiz-Ruiz J. Genetics of pathological gambling. J Gambl Stud. 2003;19:11-22.
13. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W. Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev. 2004;28:123-141.
14. Spinella M. Evolutionary mismatch, neural reward circuits, and pathological gambling. Int J Neurosci. 2003;113:503-512.
15. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325-341.
16. Gerald MS, Higley JD. Evolutionary underpinnings of excessive alcohol consumption. Addiction. 2002;97:415-425.
17. Grant JE, Potenza MN, eds. Pathological Gambling: A Clinical Guide to Treatment. Washington, DC: American Psychatric Publishing, Inc.; 2004.
18. Oakley-Browne MA, Adams P, Mobberley PM. Interventions for pathological gambling. Cochrane Database Syst Rev. 2000;2;CD001521.
19. Toneatto T, Millar G. Assessing and treating problem gambling: empirical status and promising trends. Can J Psychiatry. 2004;49:517-525.
20. Grant JE, Kim SW, Potenza MN. Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003;19:85-109.